US: India’s largest Pharm company gets summons from antitrust division

India’s largest drug maker Sun Pharmaceutical Industries Ltd said its US arm has received a summons from the antitrust division of the US department of justice, requiring it to appear before a grand jury there.

“One of the company’s US subsidiaries, Sun Pharmaceutical Industries Inc. (SPII), has received a grand jury subpoena from the United States Department of Justice (DoJ), anti-trust division,” the company said in a BSE filing.

DoJ has sought documents from SPII and its affiliates relating to corporate and employee records, generic pharmaceutical products and pricing, communications with competitors and others regarding sales of generic pharmaceutical products and certain other related matters, the company said in the BSE filing on Saturday.

The company said its unit was in the process of responding to the subpoena, adding that “the outcome of the above-referred inquiry is unlikely to have any material adverse impact” on its operations or financial results.

Full Content: Times of India

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.